CD8A and neoplasm: It is possible that such a microenvironment is critical for the induction of high quality of tumor-specific effector PD1−Tim3− CD8+T cells (Figure 5), which are capable of dramatically reducing the presence of MDSCs and improving immunotherapeutic responses in tumor-bearing mice [3].